Ticker
AVTXCompany Name
AVALO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Income Common Stock | Net Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -46.22M | -10479.82% | $ 441K |
3/31/2025 | $ 73.01M | 16556.01% | $ 441K |
12/31/2024 | $ -35.13M | -7965.76% | $ 441K |
9/30/2024 | $ -7.96M | -970.49% | $ 820K |
6/30/2024 | $ -36.22M | -4488.6% | $ 807K |
3/31/2024 | $ -142.88M | -9853.72% | $ 1.45M |
12/31/2023 | $ -31.54M | -1639.5% | $ 1.92M |
9/30/2023 | $ -33.19M | -1475.02% | $ 2.25M |
6/30/2023 | $ -24.77M | -146.01% | $ 16.96M |
3/31/2023 | $ -29.56M | -170.36% | $ 17.35M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Revenues
(=) Net %
Net % for AVALO THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -46.24M ] / Revenues [ $ -3.52M ]
(=) Net % [ 0% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.19K |
---|---|
min | -63.83% |
max | 69.74% |
average | 4.8% |
median | 5.26% |
std | 19.81% |